je.st
news
Tag: diabetes
Louisiana Ranked 4th Nationally In Rate Of Diabetes Diagnoses
2014-07-15 12:23:56| Biotech - Topix.net
Louisiana ranks 4th in the nation in the rate of diabetes diagnoses, according to the U.S. Centers for Disease Control and Prevention, with 10% of adults living with the disease.
Tags: rate
4th
louisiana
diabetes
Late-Breaking Observational Data Show Patients with Type 2 Diabetes Taking JANUVIA (sitagliptin) and Metformin Initiated Insulin Therapy at a Slower Rate Compared to Patients Taking a Sulfonylurea and Metformin
2014-06-14 19:01:32| Merck.com - Research & Development News
Dateline City: WHITEHOUSE STATION Real-world study presented at the American Diabetes Association 74th Scientific Sessions Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced results from a late-breaking observational study that assessed the differences in time to initiation of insulin use and the proportion of the population initiating insulin among patients with type 2 diabetes taking the combination of JANUVIA (sitagliptin) and metformin, and patients taking the combination of a sulfonylurea and metformin. In this study, patients treated with a combination of JANUVIA and metformin initiated insulin therapy at a slower rate during the period of observation than patients Language: English read more
New Post-Hoc Analysis Shows Patients with Type 2 Diabetes Undergoing Intensification of Insulin Therapy Experienced Less Nighttime Hypoglycemia While Being Treated with JANUVIA (sitagliptin) Compared to Placebo
2014-06-14 19:01:06| Merck.com - Research & Development News
Dateline City: WHITEHOUSE STATION Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced results from a post-hoc analysis showing that patients with type 2 diabetes having treatment intensified with insulin glargine therapy while also being treated with JANUVIA (sitagliptin) 100 mg once-daily had a lower incidence of nighttime (nocturnal) hypoglycemia compared to patients also receiving placebo. Results were presented at the American Diabetes Association 74th Scientific Sessions. Language: English read more
Merck Launches Global Patient Registry Supporting Expanded Commitment to Real-World Outcomes Research in Type 2 Diabetes
2014-06-13 14:00:00| Merck.com - Corporate News
Dateline City: WHITEHOUSE STATION, N.J. New Research Initiative Seeks to Identify Unmet Needs and Address Key Gaps in the Management of Type 2 Diabetes WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the launch of a global registry to evaluate the experiences and outcomes of approximately 20,000 patients with type 2 diabetes in real-world settings over three years. The registry is part of Mercks new global research initiative evaluating outcomes of patients with type 2 diabetes in everyday clinical practice. Language: English Contact: Media:Pam Eisele267-305-3558orKim Hamilton908-423-6831 / 908-391-0131orInvestors:Justin Holko908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: type
research
global
expanded
CDC: Diabetes count rises to 29 million
2014-06-11 21:38:20| Biotech - Topix.net
The number of people with diabetes in the United States just keeps growing, with the latest count topping 29 million, according to the federal Centers for Disease Control and Prevention.
Tags: million
count
diabetes
rises
Sites : [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] next »